Su Hee Kim | Biomedical device | Best Researcher Award

Published on by Global Academic Awards

Dr. Su Hee Kim | Biomedical device | Best Researcher Award

Dr. Su Hee Kim, Medifab co, Ltd., South Korea

Dr. Su Hee Kim, an accomplished researcher in biomedical engineering, specializes in regenerative medicine, biomaterials, and 3D bioprinting. She serves as the R&D Director at Medifab Co., Ltd., contributing to innovations in tissue engineering and healthcare materials. With a Ph.D. in Nano, Bio, and Information Technology from Korea University, her research has led to numerous patents and publications. Recognized with awards like the Best Research Award in Advanced Healthcare Materials, Dr. Kim’s pioneering work enhances patient-specific medical solutions.

Publication Profile

Scopus

Education ๐ŸŽ“

Dr. Kim earned her Ph.D. in Nano, Bio, and Information Technology from the KU-KIST Graduate School of Converging Science and Technology at Korea University (2016). Prior to that, she completed her M.S. in Biotechnology from Korea University (2010) and a B.S. in Applied Chemistry from Dongduk Womenโ€™s University (2008). Her interdisciplinary academic background has equipped her with the expertise to excel in biomaterials research, bioprinting technology, and regenerative medicine.

Experience ๐Ÿ’ผ

Dr. Kim has held leadership and research positions, including her current role as R&D Director at Medifab Co., Ltd. (2021-present). She served as a Senior Researcher and Team Lead at AMRC Korea (2019-2020) and a Research Engineer at AMRC Korea (2017-2019). Additionally, she gained extensive experience as a Post-Doc and Researcher at the Korea Institute of Science and Technology (KIST) from 2007 to 2017. Her career is defined by impactful contributions to biomaterial development and translational medical research.

Awards and Honors ๐Ÿ†

Dr. Kim’s excellence in research has been acknowledged with several prestigious awards, including the Best Research Award in Advanced Healthcare Materials (2025) and the Best R&D Award from KEIT (2024). She has also received numerous academic honors, such as the Student Oral Presentation Award (2014), SYIS Oral Presentation Award (2014), and multiple scholarships recognizing her outstanding academic achievements during her graduate studies.

Research Focus ๐Ÿ”Ž

Dr. Kim’s research focuses on regenerative medicine, 3D bioprinting, and biomaterials. Her work involves developing patient-specific grafts using biocompatible scaffolds and hydrogels for tissue regeneration. She has pioneered innovations in vascularized adipose tissue regeneration, cartilage engineering, and self-assembling peptide nanofibers. Her ongoing projects include the commercialization of osteoimmune composite materials and development of ECM bioinks, contributing significantly to advancements in healthcare materials and personalized medicine.

Publication Top Notes

๐Ÿ“š Development of Polycaprolactone Grafts with Improved Physical Properties and Body Stability using a Screw Extrusion-type 3D Bioprinter โ€“ International Journal of Bioprinting, 2022

๐Ÿ“š Novel Chitosan Dermal Filler with Enhanced Moldability and Elasticity โ€“ Macromolecular Bioscience, 2022

๐Ÿ“š Self-assembling Peptide Gels Promote Angiogenesis and Functional Recovery after Spinal Cord Injury in Rats โ€“ Journal of Tissue Engineering, 2022

๐Ÿ“š The Regeneration of Large-Sized and Vascularized Adipose Tissue Using a Tailored Elastic Scaffold and dECM Hydrogels โ€“ International Journal of Molecular Sciences, 2021

๐Ÿ“š Detection of Lysyl Oxidase Activity in Tumor Extracellular Matrix Using Peptide-Functionalized Gold Nanoprobes โ€“ Cancers, 2021

๐Ÿ“š Study on the Direct Melting Extrusion Metal 3D Printing Using Induction Heating โ€“ Journal of the Korean Society of Manufacturing Technology Engineers, 2020

๐Ÿ“š Vascularization of PLGA-Based Bio-Artificial Beds by Hypoxia-Preconditioned Mesenchymal Stem Cells for Subcutaneous Xenogeneic Islet Transplantation โ€“ Xenotransplantation, 2018

๐Ÿ“š Skin Regeneration with a Scaffold of Predefined Shape and Bioactive Peptide Hydrogels โ€“ Tissue Engineering Part A, 2018 (Cited by: -)

๐Ÿ“š TGF-ฮฒ3 Encapsulated PLCL Scaffold by a Supercritical CO2-HFIP Co-Solvent System for Cartilage Tissue Engineering โ€“ Journal of Controlled Release, 2015

๐Ÿ“š Self-Assembling Peptide Nanofibers Coupled with Neuropeptide Substance P for Bone Tissue Engineering โ€“ Tissue Engineering: Part A, 2015

 

Jiaqi Lou | Clinical medicine | Best Researcher Award

Published on by Global Academic Awards

Dr. Jiaqi Lou | Clinical medicine | Best Researcher Award

Dr. Jiaqi Lou, Ningbo No.2 Hospital, China

Lou Jiaqi, born on May 16, 1995, is a dedicated burn surgeon and researcher specializing in intestinal mucosal healing post-burn injury. He holds a Masterโ€™s degree in Burns/Surgery from Xuzhou Medical University (2019-2022) and a Bachelor’s degree in Clinical Medicine from Wenzhou Medical University Renji College (2013-2018). Currently, he serves as a Resident at Ningbo No.2 Hospitalโ€™s Department of Burns. His research focuses on circular and long non-coding RNAs in burn-induced intestinal damage, nutritional strategies for burn patients, and predictive modeling in burn care. With multiple publications in high-impact journals like Cell Death & Disease, Burns & Trauma, and Frontiers in Immunology, he has significantly contributed to advancing burn treatment methodologies. Proficient in molecular biology and bioinformatics, he actively integrates clinical practice with translational research, enhancing patient outcomes. His expertise extends to animal models, clinical nutrition, and machine learning applications in burn medicine.

Publication Profile

Scopus

Orcid

Education ๐ŸŽ“๐Ÿ“š

Lou Jiaqi pursued his Bachelorโ€™s degree in Clinical Medicine at Wenzhou Medical University Renji College (2013-2018), where he gained a solid foundation in medical sciences and clinical practice. Following this, he completed his Masterโ€™s degree in Burns/Surgery at Xuzhou Medical University (2019-2022), focusing on post-burn intestinal mucosal healing and advanced molecular techniques. His postgraduate research centered on exploring the role of circular RNAs and long non-coding RNAs in burn-induced intestinal injury, utilizing qRT-PCR, bioinformatics analysis, and adenoviral transfection techniques. He also conducted extensive studies on enteral and parenteral nutrition strategies for burn patients, integrating randomized controlled trials and systematic reviews. Throughout his academic journey, he actively engaged in laboratory and clinical research, refining his expertise in molecular biology, protein interactions, and animal modeling. His strong academic background, combined with hands-on research and clinical exposure, has shaped him into a proficient clinician-scientist in burn medicine.

Experience ๐Ÿฅ

Lou Jiaqi is a Resident at the Department of Burns, Ningbo No.2 Hospital (2022-present), where he manages burn patient care and conducts translational research. Previously, he served as a Resident at The Affiliated Huaihai Hospital of Xuzhou Medical University and The 71st Group Army Hospital of PLA (2019-2022), gaining extensive experience in burn surgery and post-burn recovery. His clinical training began with rotations at leading hospitals, including Minhang Hospital and The First Affiliated Hospital of Wenzhou Medical University (2016-2018). During his early medical career, he interned at Ningbo No.1 Hospitalโ€™s Burn Department, refining his hands-on patient care and surgical skills. His experience spans acute burn management, surgical interventions, intensive care, and nutritional strategies for burn patients. Alongside his clinical duties, he integrates machine learning and predictive modeling to enhance patient outcomes, positioning himself at the forefront of innovative burn treatment methodologies.

Awards & Honors ๐Ÿ†๐ŸŽ–๏ธ

Lou Jiaqi has received several accolades for his contributions to burn medicine and research. He was awarded the Certificate of Resident Standardization Training of China (2024), recognizing his advanced clinical expertise. His achievements in molecular biology and burn research have been acknowledged through multiple journal publications, including in Cell Biology International, Cell Death & Disease, and Burns & Trauma. He obtained the Medical Practitioners Qualification of China (2021) and the Basic Life Support Provider Certification (2022), demonstrating his commitment to patient safety and professional excellence. His studies on burn-induced intestinal injury and nutritional optimization in burn patients have earned him recognition in both national and international medical communities. With a strong research background, he has contributed to advancements in RNA-based therapies and predictive modeling, enhancing patient outcomes. His extensive training, combined with a passion for innovation, has solidified his reputation as a promising burn surgeon and scientist.

Research Focus ๐Ÿ”ฌ๐Ÿงฌ

Lou Jiaqi specializes in burn-induced intestinal mucosal healing, investigating the role of circular and long non-coding RNAs in post-burn intestinal injury. His research includes circRNA-mediated signaling pathways, ceRNA network modeling, and RNA-binding protein interactions to enhance tissue repair mechanisms. He has explored enteral and parenteral nutritional strategies to optimize burn patient recovery, conducting randomized controlled trials and systematic reviews. His expertise extends to molecular and cellular techniques such as qRT-PCR, Western blotting, ELISA, and dual-luciferase assays. Additionally, he applies machine learning and Mendelian randomization in predictive modeling for burn patient outcomes. His studies have led to significant publications in Cell Death & Disease, Burns & Trauma, and Frontiers in Immunology. By integrating basic science, clinical practice, and bioinformatics, he contributes to innovative therapeutic approaches in burn care, focusing on translational medicine and personalized treatment strategies for severe burn patients.

 

Publication Top Notes

  • “A Bidirectional Mendelian-Randomization Analyses of Genetically Predicted Circulating Levels of Systemic Inflammatory Regulators with Risk of Sepsis” (2024) examines genetic predictors of systemic inflammation and their association with sepsis risk.

    ACM Digital Library

  • “Development, Reliability, and Validity of the Second-Modified Nutrition Risk Screening 2002” (2024) focuses on enhancing nutritional risk screening tools for clinical settings.

    ACM Digital Library

  • “The Efficacy and Safety of Negative Pressure Wound Therapy in Paediatric Burns: A Systematic Review and Meta-Analysis of Randomized Controlled Trials” (2024) evaluates the effectiveness of negative pressure wound therapy in treating pediatric burn patients.

    ACM Digital Library

  • “A Two-Step, Two-Sample Mendelian Randomization Analysis Investigating the Interplay Between Gut Microbiota, Immune Cells, and Melanoma Skin Cancer” (2024) investigates the relationship between gut microbiota, immune response, and melanoma development.

    ACM Digital Library

  • “A Retrospective Study Utilizing MIMIC-IV Database to Explore the Potential Association Between Triglyceride-Glucose Index and Mortality in Critically Ill Patients with Sepsis” (2024) explores the link between triglyceride-glucose index levels and mortality rates in septic patients.

    ACM Digital Library

  • “Effects of Virtual Reality on Analgesia in Wound Care and Physical Therapy for Burn Patients: A Systematic Review and Meta-Analysis” (2024) assesses the use of virtual reality for pain management in burn care.

    ACM Digital Library

  • “Development and Validation of a Nomogram to Predict Hypothermia in Adult Burn Patients During Escharectomy Under General Anesthesia” (2024) introduces a predictive tool for hypothermia during specific surgical procedures in burn patients.

    ACM Digital Library

  • “Efficacy of Probiotics or Synbiotics in Critically Ill Patients: A Systematic Review and Meta-Analysis” (2024) examines the benefits of probiotics or synbiotics in critically ill patients.

    ACM Digital Library

  • “Causal Relationship Between the Gut Microbiome and Basal Cell Carcinoma, Melanoma Skin Cancer, Ease of Skin Tanning: Evidence from Three Two-Sample Mendelian Randomisation Studies” (2024) explores the causal links between the gut microbiome and various skin conditions.

    ACM Digital Library

  • “PRP8-Induced CircMaml2 Facilitates the Healing of the Intestinal Mucosa via Recruiting PTBP1 and Regulating Sec62” (2022) investigates molecular mechanisms involved in intestinal mucosal healing.

    ACM Digital Library